IraBraunschweigMD

Associate Professor of Clinical Medicine, Oncology, Albert Einstein College of Medicine

Dr. Braunschweig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
111 E 210th St
Bronx, NY 10467
Phone+1 718-920-4057

Fax+1 718-798-7474

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1995 - 1997
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1992 - 1995
New York University School of MedicineClass of 1992

PubMed

A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.
Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, Yogen Saunthararajah, Kira Gritsman
Blood. 2024-11-28
1 citations
Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma.
Frederick L Locke, Sattva S Neelapu, Nancy L Bartlett, Lazaros J Lekakis, Caron A Jacobson
Transplantation and Cellular Therapy. 2024-11-01
5 citations
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
David Levitz, Yogen Saunthararajah, Kateryna Fedorov, Lauren C Shapiro, Ioannis Mantzaris
Clinical Cancer Research. 2023-08-01

Abstracts/Posters

Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis
Ira Braunschweig, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Comparison of Two-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel) and SCHOLAR-1 in Patients with Refractory Large B Cell Lymphoma
Ira Braunschweig, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma Cohort
Ira Braunschweig, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019